Royalty Pharma PLC (NASDAQ:RPRX)

Delayed Data
As of May 20
 -0.25 / -0.63%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Royalty Pharma PLC have a median target of 53.00, with a high estimate of 58.00 and a low estimate of 48.00. The median estimate represents a +34.08% increase from the last price of 39.53.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in Royalty Pharma PLC. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 17

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 32.62%
Growthannually 2.61%


Growthquarterly -4.97%
Growthannually 8.55%
Key to the earnings and sales forecast charts.